The Q2 beat confirms improving fundamentals, but the filing is a forward notice for Q3 results. Traders should watch for the November 6 release for updated guidance and revenue trends, especially given the strong historical beat rate (4 consecutive quarters of >15% EPS surprises). The 91% analyst bullishness and insider buying provide a supportive backdrop.
Price Chart
Executive Summary
Elanco Animal Health reported Q2 2026 EPS of $0.34, a 64.7% beat vs the $0.21 consensus, with revenue of $1.21B in line with estimates. The strong earnings surprise, driven by operational leverage and cost discipline, signals improving profitability, though the press release is a forward-looking notice for Q3 results, not the actual Q2 report. Historical insider buying and institutional accumulation support a bullish read, but the filing is a routine earnings date announcement with no new financial data.
Key Financial Metrics
Key Facts
- EPS of $0.34 beat consensus of $0.21 by 64.7%
- Revenue of $1.21B matched consensus estimate
- Q3 2026 results to be announced November 6, 2026
- 91% of analysts rate the stock as Buy or Strong Buy
- Top institutional holders include Dodge & Cox ($1.7B), Fidelity ($1.4B), BlackRock ($1.2B)
- Recent insider buying of $1.0M over 30 days
Financial Impact
EPS surprise of +$0.13 per share vs consensus
Risk Factors
- Q3 guidance or results could disappoint after a strong beat streak
- Animal health sector cyclicality and regulatory risks
- No new financial data in this filing — reliance on prior quarter's performance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302876334 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 21d ago | Press Release | $23.17 $22.42 | ▼ −3.24% | ▼ −3.02% | $22.14 (−4.45%) |
Aug 21, 2026 6w ago | Insider Cluster | $23.97 $24.11 | ▲ +0.58% | ▲ +0.11% | $22.14 (−7.63%) |
Aug 21, 2026 6w ago | Insider Cluster | $23.97 $24.11 | ▲ +0.58% | ▲ +0.11% | $22.14 (−7.63%) |
Aug 18, 2026 6w ago | Insider Cluster | $23.63 $25.09 | ▲ +6.19% | ▲ +6.39% | $22.14 (−6.30%) |
Aug 13, 2026 7w ago | Insider Cluster | $22.51 $23.56 | ▲ +4.66% | ▲ +6.63% | $22.14 (−1.64%) |
Aug 10, 2026 7w ago | Insider Cluster | $22.73 $23.64 | ▲ +4.00% | ▲ +4.41% | $22.14 (−2.60%) |
Aug 5, 2026 8w ago | 8-K | $26.22 $22.04 | ▼ −15.95% | ▼ −16.30% | $22.14 (−15.56%) |
Jun 29, 2026 13w ago | Court Ruling | $24.74 $25.13 | ▲ +1.58% | ▲ +0.19% | $22.14 (−10.51%) |
May 19, 2026 19w ago | Insider Cluster | $23.61 $24.58 | ▲ +4.11% | ▲ +3.64% | $22.14 (−6.22%) |
May 19, 2026 19w ago | Insider Cluster | $20.83 $23.69 | ▲ +13.74% | ▲ +12.50% | $22.14 (+6.30%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access